217 related articles for article (PubMed ID: 34657627)
1. Generating evidence on the use of Image and performance enhancing drugs in the UK: results from a scoping review and expert consultation by the Anabolic Steroid UK network.
McVeigh J; Hearne E; Boardley I; Bates G; Hope V; Ralphs R; Van Hout MC
Harm Reduct J; 2021 Oct; 18(1):107. PubMed ID: 34657627
[TBL] [Abstract][Full Text] [Related]
2. Treatments for people who use anabolic androgenic steroids: a scoping review.
Bates G; Van Hout MC; Teck JTW; McVeigh J
Harm Reduct J; 2019 Dec; 16(1):75. PubMed ID: 31888665
[TBL] [Abstract][Full Text] [Related]
3. An exploratory study of image and performance enhancement drug use in a male British South Asian community.
Van Hout MC; Kean J
Int J Drug Policy; 2015 Sep; 26(9):860-7. PubMed ID: 25827056
[TBL] [Abstract][Full Text] [Related]
4. Systems mapping to understand complexity in the association between image and performance enhancing drugs (IPEDs) and harm.
Bates G; Ralphs R; Bond VW; Boardley I; Hope V; Van Hout MC; McVeigh J
Int J Drug Policy; 2022 Sep; 107():103801. PubMed ID: 35858502
[TBL] [Abstract][Full Text] [Related]
5. Image and performance enhancing drug use among men who have sex with men and women who have sex with women in the UK.
Hibbert MP; Brett CE; Porcellato LA; Hope VD
Int J Drug Policy; 2021 Sep; 95():102933. PubMed ID: 32912823
[TBL] [Abstract][Full Text] [Related]
6. Secondary distribution of injecting equipment obtained from needle and syringe programmes by people injecting image and performance enhancing drugs: England and Wales, 2012-15.
Glass R; Hope VD; Njoroge J; Edmundson C; Smith J; McVeigh J; Parry J; Desai M
Drug Alcohol Depend; 2019 Feb; 195():40-44. PubMed ID: 30580202
[TBL] [Abstract][Full Text] [Related]
7. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
8. Intervention Now to Eliminate Repeat Unintended Pregnancy in Teenagers (INTERUPT): a systematic review of intervention effectiveness and cost-effectiveness, and qualitative and realist synthesis of implementation factors and user engagement.
Whitaker R; Hendry M; Aslam R; Booth A; Carter B; Charles JM; Craine N; Tudor Edwards R; Noyes J; Ives Ntambwe L; Pasterfield D; Rycroft-Malone J; Williams N
Health Technol Assess; 2016 Feb; 20(16):1-214. PubMed ID: 26931051
[TBL] [Abstract][Full Text] [Related]
9. Support for people who use Anabolic Androgenic Steroids: A Systematic Scoping Review into what they want and what they access.
Harvey O; Keen S; Parrish M; van Teijlingen E
BMC Public Health; 2019 Jul; 19(1):1024. PubMed ID: 31366349
[TBL] [Abstract][Full Text] [Related]
10. Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.
Rees S; Williams A
JBI Libr Syst Rev; 2009; 7(13):492-582. PubMed ID: 27819974
[TBL] [Abstract][Full Text] [Related]
11. Harm Reduction in Male Patients Actively Using Anabolic Androgenic Steroids (AAS) and Performance-Enhancing Drugs (PEDs): a Review.
Bonnecaze AK; O'Connor T; Burns CA
J Gen Intern Med; 2021 Jul; 36(7):2055-2064. PubMed ID: 33948794
[TBL] [Abstract][Full Text] [Related]
12. The risk environment of anabolic-androgenic steroid users in the UK: Examining motivations, practices and accounts of use.
Hanley Santos G; Coomber R
Int J Drug Policy; 2017 Feb; 40():35-43. PubMed ID: 27955960
[TBL] [Abstract][Full Text] [Related]
13. Risk and blood-borne virus testing among men who inject image and performance enhancing drugs, Sydney, Australia.
Rowe R; Berger I; Yaseen B; Copeland J
Drug Alcohol Rev; 2017 Sep; 36(5):658-666. PubMed ID: 28244160
[TBL] [Abstract][Full Text] [Related]
14. The injecting use of image and performance-enhancing drugs (IPED) in the general population: a systematic review.
Brennan R; Wells JSG; Van Hout MC
Health Soc Care Community; 2017 Sep; 25(5):1459-1531. PubMed ID: 26806443
[TBL] [Abstract][Full Text] [Related]
15. The unintended consequences of emphasising blood-borne virus in research on, and services for, people who inject image and performance enhancing drugs: A commentary based on enhanced bodybuilder perspectives.
Underwood M
Int J Drug Policy; 2019 May; 67():19-23. PubMed ID: 30844641
[TBL] [Abstract][Full Text] [Related]
16. Health care engagement behaviors of men who use performance- and image-enhancing drugs in Australia.
Jacka B; Larance B; Copeland J; Burns L; Farrell M; Jackson E; Degenhardt L
Subst Abus; 2020; 41(1):139-145. PubMed ID: 31545138
[No Abstract] [Full Text] [Related]
17. Environments, risk and health harms: a qualitative investigation into the illicit use of anabolic steroids among people using harm reduction services in the UK.
Kimergård A; McVeigh J
BMJ Open; 2014 Jun; 4(6):e005275. PubMed ID: 24898090
[TBL] [Abstract][Full Text] [Related]
18. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
Allen D; Gillen E; Rixson L
JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
[TBL] [Abstract][Full Text] [Related]
19. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
